Schrodinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Schrodinger has a growing pipeline of early-stage assets and has co-founded leading biotech companies, including Nimbus Therapeutics and Morphic Therapeutic. In addition, the company has deep partnerships and collaborations in such fields as biotechnology, pharmaceuticals, chemicals, and electronics. Through significant long-term investments in basic research, Schrodinger has made scientific breakthroughs across many areas of drug discovery and materials science. Founded in 1990, Schrodinger has nearly 400 employees and operations in the United States, Europe, Japan, and India, as well as business partners in China and Korea
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/19 | $85,000,000 |
Bill & Melinda Gates Foundation Deerfield Management Company, L.P. Qiming Venture Partners WuXi AppTec | undisclosed |
